Aprea (APRE) Net earnings per share growth forecast for next year

Corporate company logo of Aprea Therapeutics, Inc. (APRE)

Aprea Therapeutics (APRE) focuses on individualized clinical trials in the field of DNA repair, limiting its partnerships to a narrow circle of research centers. Its ecosystem of targeted drugs creates a closed scientific loop, tying medical centers to its own protocols. This innovative approach allows for the identification of vulnerabilities in the defenses of complex tumors. The estimated growth in net income per share for the coming year demonstrates market optimism, where the level of -9.90 reflects the current magnitude.

Aprea (APRE): Net earnings per share growth forecast for next year from 07/04/2022 to 11/14/2026

Summary analytical data breakdowns for Aprea Therapeutics (APRE)

- share price and consensus valuation forecast:
Stock Price aprea.com|APRE - Consensus Target
- market capitalization details:
Market Value Aprea Therapeutics|APRE - Total Enterprise Value
- company book value details:
Net Assets per Single Share Aprea Therapeutics|APRE - Company Book Value|Market Value to Book Value Ratio aprea.com|APRE - Company Assets
- issuer credit burden and liquidity indicators:
Total Debt to Capital Aprea Therapeutics|APRE - Long-Term Indebtedness to Equity|Short-Term Debt to Equity Ratio Aprea Therapeutics Inc.|APRE - Company Cumulative Debt|Debt to Book Value Aprea|APRE - Company Long-Term Loans and Borrowings|Company Current Liabilities Aprea Therapeutics|Quick Ratio aprea.com
- net income and valuation ratios data:
APRE - Final Profit|Projected Future Earnings Aprea Therapeutics|APRE - Market Cap to Earnings|Future Price to Earnings aprea.com|APRE - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Aprea Therapeutics, Inc.|APRE - Operating profit EBITDA|Earnings per share for the last twelve months Aprea Therapeutics|APRE - Earnings per one share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months aprea.com|APRE - Earnings per share growth rate in current year|Earnings growth forecast for next year Aprea Therapeutics
- company sales and revenue statistics:
APRE - Revenue and Sales Volume|Company Projected Revenue Aprea|APRE - Price-to-Sales Ratio|Price-to-Projected Revenue Ratio Aprea
Fundamental company analysis:Aprea Therapeutics Inc.
Finished products of Aprea

The success of Aprea Therapeutics (APRE) depends on the results of clinical trials for oncology drugs funded by investments. This indicator measures the percentage change in expected earnings per share, reflecting the analysts' consensus forecast for the future monetization of developments, which allows investors to assess the fairness of the current stock price through the projected annual EPS dynamics of the company.

Competitor analysis for Aprea Therapeutics

INCY (incyte.com) - Earnings growth forecast for next year|Expected net earnings per share growth next year hutch-med.com HCM|Net earnings per share growth forecast for next year Nuvation Corp (NUVB)|DAWN - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Monopar Pharma MNPR|Inhibrx Corp - Net earnings per share growth forecast for next year|IMAB - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Fennec Pharmaceuticals|HRTX: Earnings growth forecast for next year|Net earnings per one share growth forecast for next year Nuvectis NVCT|Expected earnings per share growth for next year CHRS|Expected net earnings per share growth next year Corbus Pharmaceuticals CRBP|Expected earnings per share growth for next year CRDF (Cardiff Oncology Inc.)|BYSI (BeyondSpring) - Expected earnings per share trend next year|BioAtla - Expected earnings per share growth for next year|Projected earnings per share increase next year LIXT (Lixte Biotechnology Holdings, Inc.)|Citius Pharmaceuticals, Inc. - Earnings growth forecast for next year|Expected earnings per share trend next year CLRB (Cellectar)|BLRX: Earnings growth forecast for next year|Expected net earnings per share growth next year canfite.com (CANF)|Net earnings per share growth forecast for next year kaziatherapeutics.com|SLXN: Expected earnings per share trend next year|Earnings growth forecast for next year NCNA|Earnings growth forecast for next year Chimerix Inc (CMRX)|Net earnings per share growth forecast for next year Cyclacel Pharmaceuticals Inc. CYCC|GTHX (g1therapeutics.com) - Net earnings per share change forecast for next year|KRON: Expected earnings per share growth for next year|Expected net earnings per share growth next year Kintara Therapeutics Inc|oncternal.com (ONCT) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year PRTG (Portage Biotech Corp)